BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23652954)

  • 1. Iododerma following serial computed tomography scans in a lung cancer patient.
    Rothman LR; Levender MM; Scharf MD; Herman SP; Jabbari A
    J Drugs Dermatol; 2013 May; 12(5):574-6. PubMed ID: 23652954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute iododerma secondary to iodinated contrast media.
    Young AL; Grossman ME
    Br J Dermatol; 2014 Jun; 170(6):1377-9. PubMed ID: 24471498
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of topical povidone-iodine resulting in an iododerma-like eruption.
    Massé M; Falanga V; Zhou LH
    J Dermatol; 2008 Nov; 35(11):744-7. PubMed ID: 19120771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vegetative plaques and hemorrhagic pustules. Iododerma.
    Stavert R; Bunick CG; Modi B; Robinson DM; Ibrahim O; Knopp E; Tigelaar R; Imaeda S
    JAMA Dermatol; 2013 Oct; 149(10):1231-2. PubMed ID: 23925362
    [No Abstract]   [Full Text] [Related]  

  • 5. Iododerma and acute respiratory distress with leucocytoclastic vasculitis following the intravenous injection of contrast medium.
    Vaillant L; Pengloan J; Blanchier D; De Muret A; Lorette G
    Clin Exp Dermatol; 1990 May; 15(3):232-3. PubMed ID: 2142030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iododerma after computed tomographic scan with intravenous radiopaque contrast media.
    Chang MW; Miner JE; Moiin A; Hashimoto K
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):1014-6. PubMed ID: 9204072
    [No Abstract]   [Full Text] [Related]  

  • 7. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
    Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH
    J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Halogen halos: Report of an early histopathologic finding in iododerma.
    Bitterman A; Zundell MP; Psomadakis C; Kasago I; Phelps R; Niedt G; Khattri S
    J Cutan Pathol; 2023 Sep; 50(9):806-809. PubMed ID: 37394806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU.
    Ng CS; Shaw AD; Bell CS; Samuels JA
    AJR Am J Roentgenol; 2010 Aug; 195(2):414-22. PubMed ID: 20651198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late phase allergic reaction to a CT contrast medium (iotrolan).
    Kanzaki T; Sakagami H
    J Dermatol; 1991 Sep; 18(9):528-31. PubMed ID: 1838559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late skin reaction to iodixanol (Visipaque): clinical manifestations, patch test study, and histopathological evaluation.
    Delgado-Jimenez Y; Perez-Gala S; Aragüés M; Sanchez-Perez J; Garcia-Diez A
    Contact Dermatitis; 2006 Dec; 55(6):348-53. PubMed ID: 17101010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iododerma following topical povidone-iodine application.
    Aliagaoglu C; Turan H; Uslu E; Albayrak H; Yazici S; Kaya E
    Cutan Ocul Toxicol; 2013 Oct; 32(4):339-40. PubMed ID: 23560395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol.
    Barrett BJ; Katzberg RW; Thomsen HS; Chen N; Sahani D; Soulez G; Heiken JP; Lepanto L; Ni ZH; Ni ZH; Nelson R
    Invest Radiol; 2006 Nov; 41(11):815-21. PubMed ID: 17035872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [No detectable nephrotoxic side effect using a dimer, non-ionic contrast media in cerebral perfusion computed tomography in case of suspected brain ischemia].
    Petrik M; Weigel C; Kirsch M; Hosten N
    Rofo; 2005 Sep; 177(9):1242-9. PubMed ID: 16123870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed drug eruption associated with intravenous contrast media: report in a woman receiving iohexol.
    Wright NA; Cohen PR
    J Drugs Dermatol; 2011 Jul; 10(7):802-4. PubMed ID: 21720665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
    Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH
    Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute generalized exanthematous pustulosis as a delayed dermatotoxic reaction to IV-administered nonionic contrast media.
    Peterson A; Katzberg RW; Fung MA; Wootton-Gorges SL; Dager W
    AJR Am J Roentgenol; 2006 Aug; 187(2):W198-201. PubMed ID: 16861512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bullous fixed drug eruption in a patient with metastatic renal cell carcinoma induced by iodinated contrast during pazopanib treatment.
    Epskamp C; Snels DG; Yo GL; Zuetenhorst HJ; Hamberg P
    Eur J Dermatol; 2016 Apr; 26(2):207-8. PubMed ID: 26905214
    [No Abstract]   [Full Text] [Related]  

  • 19. The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography.
    Thomsen HS; Morcos SK; Erley CM; Grazioli L; Bonomo L; Ni Z; Romano L;
    Invest Radiol; 2008 Mar; 43(3):170-8. PubMed ID: 18301313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMAGES IN CLINICAL MEDICINE. Iododerma from Contrast Material.
    Chalela JG; Aguilar L
    N Engl J Med; 2016 Jun; 374(25):2477. PubMed ID: 27332906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.